Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
How Optum Rx can help you manage GLP-1/GIP trend Given the complex and evolving nature of this drug class, plan sponsors need a strategic partner with the capabilities to provide options and management strategies to help balance cost and utilization of GLP-1s
45% of individuals in the combination therapy group experienced at least a 20% reduction in body mass
Hims & Hers analyst ratings and price targets are on MarketBeat
Zhang, F., Huang, B., Zhong, B., Zhou, H., Wang, L., Zheng, Q., & Lin, Y
US$ 27.14
US$ 29.01
US$ 21.52
US$ 20.09
